New ‘cocktail’ drug could benefit up to 45 per cent of patients with Duchenne muscular dystrophy — ScienceDaily
A new "cocktail" drug being made at the College of Alberta could deliver an powerful and cost-effective treatment method to...
A new "cocktail" drug being made at the College of Alberta could deliver an powerful and cost-effective treatment method to...